TOSI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.684
EU - Europa 13.499
AS - Asia 10.690
SA - Sud America 1.501
AF - Africa 201
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 17
Totale 53.629
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.443
GB - Regno Unito 4.522
IT - Italia 3.801
CN - Cina 3.562
SG - Singapore 3.065
HK - Hong Kong 1.686
SE - Svezia 1.305
BR - Brasile 1.224
DE - Germania 867
RU - Federazione Russa 619
TR - Turchia 576
UA - Ucraina 565
VN - Vietnam 532
FI - Finlandia 487
FR - Francia 319
KR - Corea 315
BG - Bulgaria 221
IN - India 214
NL - Olanda 143
ID - Indonesia 142
CA - Canada 116
AR - Argentina 103
JP - Giappone 95
ES - Italia 87
IE - Irlanda 87
ZA - Sudafrica 75
BD - Bangladesh 74
BE - Belgio 74
MX - Messico 72
PL - Polonia 70
RO - Romania 68
IQ - Iraq 66
LT - Lituania 60
EC - Ecuador 46
IR - Iran 45
CH - Svizzera 41
PK - Pakistan 41
IL - Israele 40
MY - Malesia 35
CO - Colombia 34
AE - Emirati Arabi Uniti 33
EG - Egitto 31
AT - Austria 26
AU - Australia 25
MA - Marocco 24
UZ - Uzbekistan 24
VE - Venezuela 24
CZ - Repubblica Ceca 21
GR - Grecia 20
PY - Paraguay 19
EE - Estonia 18
PT - Portogallo 18
CL - Cile 17
UY - Uruguay 15
AZ - Azerbaigian 14
EU - Europa 14
DZ - Algeria 13
JO - Giordania 12
KZ - Kazakistan 12
TN - Tunisia 12
TW - Taiwan 12
NZ - Nuova Zelanda 11
SN - Senegal 11
SA - Arabia Saudita 10
BO - Bolivia 9
HU - Ungheria 9
KE - Kenya 9
NO - Norvegia 9
AL - Albania 8
DK - Danimarca 8
PE - Perù 8
PH - Filippine 8
CR - Costa Rica 7
JM - Giamaica 7
KG - Kirghizistan 7
NP - Nepal 7
AM - Armenia 6
LA - Repubblica Popolare Democratica del Laos 6
LK - Sri Lanka 6
OM - Oman 6
TH - Thailandia 6
BZ - Belize 5
DO - Repubblica Dominicana 5
HN - Honduras 5
LB - Libano 5
NI - Nicaragua 5
PA - Panama 5
PS - Palestinian Territory 5
BY - Bielorussia 4
ET - Etiopia 4
KH - Cambogia 4
LV - Lettonia 4
LY - Libia 4
MD - Moldavia 4
MK - Macedonia 4
NG - Nigeria 4
TT - Trinidad e Tobago 4
YE - Yemen 4
GE - Georgia 3
GT - Guatemala 3
Totale 53.580
Salva come PNG Salva come JPEG
Città #
Southend 3.452
Santa Clara 2.622
Ashburn 2.233
Fairfield 2.221
Singapore 1.859
Chandler 1.671
Hong Kong 1.658
Woodbridge 1.618
Hefei 1.272
Jacksonville 1.139
Chicago 1.084
Houston 1.005
Seattle 963
Wilmington 937
Dearborn 876
Ann Arbor 776
Nyköping 761
Cambridge 747
Los Angeles 693
Beijing 640
London 596
Modena 541
San Jose 471
Salt Lake City 394
Izmir 326
New York 268
Helsinki 255
Seoul 252
The Dalles 247
Dallas 237
Princeton 235
Sofia 216
Council Bluffs 203
San Diego 201
Eugene 200
Milan 195
Ho Chi Minh City 191
Tampa 170
Bologna 169
Elk Grove Village 167
Moscow 162
Rome 148
Shanghai 128
Buffalo 125
Munich 124
São Paulo 123
Redwood City 121
Jakarta 109
Hanoi 106
Bremen 94
Falls Church 93
Lancaster 91
Des Moines 84
Fremont 84
Frankfurt am Main 80
Reggio Emilia 80
Sterling 79
Tokyo 78
Dublin 73
Miami 70
Columbus 69
Phoenix 67
Brussels 65
Parma 60
Dulles 53
Florence 53
Orem 53
Guangzhou 48
Naples 48
Boardman 47
Brooklyn 47
Stockholm 47
Warsaw 47
Detroit 45
Nanjing 44
Atlanta 42
Como 41
Johannesburg 40
Denver 39
Tulare 39
Chennai 38
Napoli 37
Norwalk 37
Rio de Janeiro 35
Turin 34
Catania 33
Kunming 32
Montreal 32
Kent 30
Baghdad 29
Bari 29
Padova 29
Poplar 29
Zhengzhou 29
Redondo Beach 28
Turku 28
Belo Horizonte 27
Istanbul 27
Boston 26
Haiphong 26
Totale 37.422
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 517
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 464
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 448
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 433
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 411
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 409
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 400
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 395
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 395
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 392
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 388
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 386
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 384
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 381
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 379
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 375
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 373
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 372
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 365
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 359
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 359
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 354
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 352
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 348
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 348
Chemo-enzymatic synthesis of levodropropizine 348
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 347
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 343
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 343
Nanomedicine: the future for advancing medicine and neuroscience 337
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 337
Vegetable cells in Papanicolaou-stained cervical smears 334
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 334
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 333
Polymeric nanoparticles for the drug delivery to the central nervous system 328
Brain targeting with polymeric nanoparticles: which administration route should we take? 327
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 325
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 322
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 319
Nanoparticle transport across the blood brain barrier 318
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 318
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 317
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 316
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 314
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 309
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 309
Advances and perspectives for Central Nervous System drug delivery: the interface between nanotechnology and neuroscience 307
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 306
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 305
Protein corona and nanoparticles: How can we investigate on? 305
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 301
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 298
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 298
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 296
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 294
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 294
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 290
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 287
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 285
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 284
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 284
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 282
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 281
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 281
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 280
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 278
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 278
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 275
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 275
Colloidal systems for CNS drug delivery 274
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 273
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 273
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 273
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 270
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 267
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 265
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 265
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 264
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 263
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 263
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 262
Functionalization of liposomes: microscopical methods for preformulative screening 262
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 258
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 257
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 256
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 255
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 253
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 252
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 248
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 244
Ketorolac tromethamine liposomes: Encapsulation and release studies 242
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 241
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 238
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 236
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 231
Application of poly-L-lactide screws in flat foot surgery: Histological and radiological aspects of bio-absorption of degradable devices 231
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 229
Brain targeting by engineered nanoparticles 227
Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers 226
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 225
Totale 31.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 213.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 213.642
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.745 0 0 0 0 0 0 459 655 255 834 313 229
2021/20224.031 178 482 379 242 154 210 213 222 483 320 642 506
2022/20234.655 577 548 362 472 544 622 125 411 528 74 190 202
2023/20243.511 165 197 221 285 793 356 401 418 109 107 169 290
2024/202510.855 500 175 228 827 2.043 1.474 851 771 1.053 466 1.099 1.368
2025/202612.758 1.308 808 1.504 2.778 4.373 1.321 666 0 0 0 0 0
Totale 54.026